Physician profile
Rupal Patel
NPI 1083337745
$4,385.29
in general payments reported to CMS, 2019-2025
15 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,748 · 2024: $1,288 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,293 · Travel and Lodging: $1,080 · Education: $12.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,292.75 |
| Travel and Lodging | $1,080.39 |
| Education | $12.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,836.65 | 2023-2025 | Spravato |
| Abbvie INC. | $528.56 | 2023-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $420.98 | 2023-2024 | Caplyta |
| Tris Pharma INC | $367.54 | 2023-2024 | Dyanavel Xr, Quillichew Er, Quillivant |
| Otsuka America Pharmaceutical, INC. | $317.45 | 2023-2025 | Rexulti, Abilify Maintena |
| Axsome Therapeutics, INC. | $207.00 | 2023-2024 | Auvelity, Sunosi |
| Corium, LLC | $153.11 | 2023 | Azstarys |
| Boston Scientific Corporation | $133.05 | 2024 | Exalt Model D |
| Supernus Pharmaceuticals, INC. | $126.79 | 2023 | Qelbree |
| Almatica Pharma LLC | $70.72 | 2023-2025 | Loreev Xr, Sertraline Hcl |
| Ironshore Pharmaceuticals INC. | $55.70 | 2023 | Jornay Pm |
| Noven Therapeutics, LLC | $53.84 | 2024 | Secuado, Xelstrym |
| Alkermes, INC. | $48.60 | 2023 | Lybalvi |
| Neos Therapeutics, Lp | $33.28 | 2024 | Adzenys Xr-Odt |
| Idorsia Pharmaceuticals US INC | $32.02 | 2024 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rupal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.